- Home
- MAN vs AMRX Comparison
MAN vs AMRX Comparison
Compare MAN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAN
- AMRX
- Stock Information
- Founded
- MAN 1948
- AMRX 2002
- Country
- MAN United States
- AMRX United States
- Employees
- MAN N/A
- AMRX N/A
- Industry
- MAN Professional Services
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- MAN Consumer Discretionary
- AMRX Health Care
- Exchange
- MAN Nasdaq
- AMRX Nasdaq
- Market Cap
- MAN 2.0B
- AMRX 2.3B
- IPO Year
- MAN 1988
- AMRX N/A
- Fundamental
- Price
- MAN $41.94
- AMRX $7.32
- Analyst Decision
- MAN Hold
- AMRX Strong Buy
- Analyst Count
- MAN 6
- AMRX 4
- Target Price
- MAN $57.50
- AMRX $11.50
- AVG Volume (30 Days)
- MAN 908.3K
- AMRX 1.9M
- Earning Date
- MAN 07-17-2025
- AMRX 05-02-2025
- Dividend Yield
- MAN 5.39%
- AMRX N/A
- EPS Growth
- MAN 129.57
- AMRX N/A
- EPS
- MAN 2.33
- AMRX N/A
- Revenue
- MAN $17,540,900,000.00
- AMRX $2,830,186,000.00
- Revenue This Year
- MAN N/A
- AMRX $10.20
- Revenue Next Year
- MAN $2.46
- AMRX $7.15
- P/E Ratio
- MAN $18.03
- AMRX N/A
- Revenue Growth
- MAN N/A
- AMRX 13.42
- 52 Week Low
- MAN $38.10
- AMRX $6.29
- 52 Week High
- MAN $78.22
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- MAN 42.42
- AMRX 46.61
- Support Level
- MAN $41.86
- AMRX $7.02
- Resistance Level
- MAN $42.90
- AMRX $7.39
- Average True Range (ATR)
- MAN 0.90
- AMRX 0.18
- MACD
- MAN 0.30
- AMRX -0.00
- Stochastic Oscillator
- MAN 15.59
- AMRX 45.80
About MAN ManpowerGroup
ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.